Assessing the Unsustainable Cost of Specialty Medications

A Survey of Public Sector Health Plans 2024

The National Institute for Public Employee Healthcare Policy, in partnership with the Public Sector HealthCare Roundtable, released its annual report on the cost of specialty medications. 

The report surveyed plan sponsors who provided 17 responses across 13 states, representing more than 78 health plans. These organizations provide benefit coverage to 1.2 million lives, with a total drug spend of $8.9 billion dollars in the year 2023, including $4.1 billion dollars on specialty drugs.